EQUITY (Details Narrative) (USD $)	12 Months Ended			55 Months Ended	12 Months Ended
	Feb. 28, 2014	Feb. 28, 2013	Feb. 29, 2012	Feb. 28, 2014	Feb. 28, 2012 MBM Agreement [Member]	Feb. 28, 2014 Advisory And Clinical [Member]	Feb. 28, 2014 Director [Member]	Feb. 28, 2014 Consultant and Advisor [Member]	Feb. 28, 2014 Consultant [Member]	Feb. 28, 2014 2013 Note Holder [Member]
Share Exchange Agreement
Common stock issued pursuant to agreement					18,369,421
Remaining common stock outstanding prior to Exchange					840,000
Common stock sold for proceeds		880,000	865,000
Proceeds from sale of common stock		$ 880,000	$ 865,000	$ 3,418,755
Issuance of restricted stock to board of directors for services		100,000
Expense of restricted stock issuance		5,270
Common stock issued							150,000	112,000	12,000	92,468
Restricted stock issued						153,013
Achievement goal							5,000,000
Fair value							375,000	284,200	15,000
Stock compensation expense								284,200
Allocated to research and development expense	824,336	516,798		2,365,539				187,500
Allocated to general and administrative expense	3,526,863	2,000,937		7,345,295				96,700
Convertible promissory notes issued										$ 1,387,000